More articles from ODT: In vitro and In vivo Oncology 

You have access
Harnessing LDLR-targeted radiolabeled peptide for imaging in pancreatic adenocarcinoma (PDAC)
Izabela Tworowska, Leo Flores ii, Cedric Malicet, Xiaomei Qu, Perry Davis, Pascaline Lecorche, Jamal Temsamani and Ebrahim Delpassand

Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 251896;
You have access
Simultaneous targeting of EGFR-positive TNBC xenografts using epitope-specific [225Ac]Ac-labeled nimotuzumab and [161]Tb-labeled matuzumab results in enhanced therapeutic effects
Dede Fon, Florence Tikum, Fabrice ngoh Njotu, Jessica Pougoue ketchemen, Nikita Henning, Hanan Babeker, Maruti Uppalapati and Humphrey Fonge

Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 252248;
You have access
Development of a Peptide-Drug Conjugate to Enhance DNA Alkylating Effects in Neuroendocrine Tumors
Tyler Bateman, Jack Adams, Sukhen Ghosh, Vahid Khalaj, Ali Azhdarinia and Solmaz Aghaamiri

Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 251844;
You have access
PET imaging and optimization of HER2 modulation in HER2-low breast tumors to enhance therapeutic efficacy
Patricia Ribeiro pereira, Alexander Vanover, Cristina Simó, Alex Benton, Farrokh Dehdashti and Andrew Davis

Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 252245;
You have access
Covalent conjugation of engineered extracellular vesicles with TIGIT nanobodies for targeted therapeutic delivery
Rong Guo, Rui An, Xiaoli Lan and Dawei Jiang

Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 252198;
You have access
AI Optimized Cocktails of 225Ac-based Radiopharmaceutical Therapies versus Monotherapies in Models of Liver Cancer
Hima Tallam, Sukhwinder Singh, Sushil Tripathi, Freddy e Escorcia and Roger Howell

Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 252156;
You have access
Analysis of radiation-induced DNA damage and cell cycle changes in prostate cancer cell lines depending on PSMA/AR expression
Jung Hyunseung, Keon wook Kang and Hyewon Youn

Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 252139;
You have access
Development and Validation of RPT-Specific Analytical Models for Cancer Cell Survival Prediction
Marc Ryhiner, Yangmeihui Song, Axel Rominger, Wolfgang Weber, Susanne Kossatz, Kuangyu Shi and Gerhard Glatting

Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 251835;
You have access
Conditional GAN-based Approach to Predicting Y-90 Radioembolization Dose Distibutions
Kajetan Wysoczynski, Brahim Mehadji and Emilie Roncali

Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 251939;
You have access
Novel anti-Mesothelin PET Tracer: Design, Synthesis, and Biological Evaluation
Yogindra Vedvyas, Yanping Yang, Charles Shoemaker and Moonsoo Jin

Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 251993;

Main menu

User menu

Search

More articles from ODT: In vitro and In vivo Oncology

Pages